Selexis CHO Cells in Suspension-1

Protein Expression Technologies

Selexis SUREtechnology Platform™enabling scientific pioneers to cross the finish line first.

Leveraging advanced gene technology and a proprietary cell line to discover, develop and manufacture biologic drugs and vaccines, SUREtechnology Platform improves manufacturing safety and significantly shortens development timelines—all while lowering costs and improving protein expression levels.

Selexis’ commitment to innovation has enabled the development and ongoing optimization of the most robust and flexible mammalian protein expression platform in the industry. SUREtechnology Platform improves the way that mammalian cells are used in the discovery, development and manufacturing of many recombinant protein drugs.

Selexis SUREtechnology Platform

Selexis SUREtechnology Platform for protein Expression in CHO cells